NCT06238115View on ClinicalTrials.gov

Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

March 4, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

June 1, 2025

Conditions
Unruptured Intracranial AneurysmFlow DiverterStent-assisted CoilingThromboembolic Events
Interventions
DRUG

Tirofiban

Initial infusion of 0.4μg/kg body weight/minute over 30 minutes, followed by a continuous infusion of 0.1μg/kg body weight/minute for 24 hours.

DRUG

aspirin, clopidogrel

aspirin 100 mg/day, clopidogrel 75 mg/day

Trial Locations (1)

Unknown

RECRUITING

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER